Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Allergan News Editors

News Widget

Display the Allergan news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Allergan News

News on Allergan (Ticker: AGN) continually updated from thousands of sources around the net.

Yesterday | PR-inside.com

Allergan, Inc. a " Product Pipeline Review a " H2 2011 -...

A A A' Product Pipeline Review A A A' H2 2011 - a new company profile report on companiesandmarkets.com Allergan, Inc.

Comment?

Related Topix: Biotech

Thu Feb 09, 2012

The Economist

Cosmetic treatment for men: Beauty and the beasts

IN GEORGES ROMAN'S clinic in London, women queue to see a cosmetic dermatologist renowned for zapping wrinkles and smoothing brows.

Comment?

Related Topix: Medicine, Dermatology, Biotech

Wed Feb 08, 2012

Wall St. Cheat Sheet

Equity Analysis: Amazon.com's Kindle Catalyst, Micron Tech, Zynga, Allergan

Amazon.com Inc. : Pacific Crest increased its 2012 estimate for unit sales of Amazon's Kindle Fire to 14.9M from 12.7M. The firm believes that increased adoption of Kindle Fire tablets should drive share gains for Amazon over the longer term, but it maintains a Sector Perform rating on the stock.

Comment?

Related Topix: Semiconductors, Biotech, Micron Technology, Amazon, Electronics, Manufacturing, RegalBeloit

AmericanBankingNews.com

Allergan (AGN) Share Price Target Raised to $98.00 by Morgan Stanley (MS) Analysts

Research analysts at Morgan Stanley increased their price target on shares of Allergan from $90.00 to $98.00 in a report issued on Wednesday.

Comment?

Related Topix: Biotech, Investment Banking, Financial Services, Morgan Stanley

KTVN Reno

2 LA clinics temporarily halt Lap-Band surgeries

Two Los Angeles-area outpatient clinics affiliated with the 1-800 GET-THIN marketing company have temporarily stopped Lap-Band weight-loss surgeries while they conduct a review of the procedure.

Comment?

Related Topix: Allergan, Biotech

Mon Feb 06, 2012

Vision Monday

Allergan Reports Rise in Fourth Quarter 2011 Sales

IRVINE, Calif. - Allergan, Inc. reported $1,382.8 million total product net sales for the fourth quarter ended Dec.

Comment?

Related Topix: Biotech, Irvine, CA

Sat Feb 04, 2012

AmericanBankingNews.com

Allergan Reports Inline Results And Gives Mixed Guidance

Allergan reported Q4 EPS of $1.00, inline with estimates. Revenues came in at $1.4 billion, which was also inline with estimates as well.Allergan said it sees 2012 EPS of $4.13 - $4.19, vs.

Comment?

Related Topix: Biotech

Fri Feb 03, 2012

AmericanBankingNews.com

Zacks Investment Research Analysts Reiterate a "Neutral" Rating on Allergan

Allergan 's stock had its "neutral" rating reaffirmed by Zacks Investment Research in a report issued on Friday.

Comment?

Related Topix: Barclays plc, Banking, Biotech

The Huffington Post

Lap-Band Maker, Allergen, Halts Sales To 1-800-GET-THIN Clinics

Five Southland patients have died since 2009 after undergoing Lap-Band surgeries in 1-800-GET-THIN clinics in Beverly Hills and West Hills, according to the Times .

Comment?

Related Topix: Biotech, Allergan

Reuters

Allergan to rely less on U.S. for sales, Asia key

Allergan Inc, maker of wrinkle treatment Botox, eye drops and obesity treatments, said it will rely less on the United States for revenue in coming years as its products gain wider acceptance in Asia, particularly China.

Comment?

Related Topix: Biotech

Thu Feb 02, 2012

MarketNewsVideo

Daily Dividend Report: UNP, V, LVS, AGN, PRGO

This morning, Union Pacific declared its quarterly dividend of 60 cents per share, maintaining the amount paid to shareholders last quarter.

Comment?

Related Topix: Transportation, Union Pacific, Railroads, Biotech, Business News, Video

Drugs.com

Allergan Reports Fourth Quarter 2011 Operating Results

IRVINE, Calif.-- --Feb 2, 2012 - Allergan, Inc. today announced operating results for the quarter ended December 31, 2011.

Comment?

Related Topix: Biotech, Allergan, Irvine, CA

Seeking Alpha

Allergan Management Discusses Q4 2011 Results - Earnings Call Transcript

Hello, and welcome to the Allergan Fourth Quarter 2011 Earnings Call. [Operator Instructions] At the request of the company, today's conference is being recorded.

Comment?

Related Topix: Allergan, Biotech, Financial Markets

Wall St. Cheat Sheet

Wall Street Analyst Alerts: Dow Chemical, Micron Tech, Allergan, Core Labs

Micron Technology Inc. : Pacific Crest views planned capex reductions at both Elpida and Hynix as a positive for Micron and the DRAM industry.

Comment?

Related Topix: Semiconductors, Biotech, Micron Technology, Electronics, Energy, Oil & Gas, Core Laboratories

Dana Point News

Allergan halts Lap-Band sales to surgery chain

Allergan will no longer sell its Lap-Band to theA surgical centersA affiliated with theA controversial 1-800-Get-Thin marketing campaign.

Comment?

Related Topix: Biotech, Medicine, Surgery, Allergan, Irvine, CA, US Politics, US News, US House of Representatives, Henry Waxman, Democrat

Reuters

Allergan 4th-quarter profit, eye drug sales rise

The company's forecast for 2012 was lower than anticipated, sending its shares down as much as 2.8 percent, although some analysts consider the outlook conservative.

Comment?

Related Topix: Biotech, Allergan, Medicine, Migraine

Wall St. Cheat Sheet

Allergan Inc. Earnings: Margins Expand Again, Profit Rises

S&P 500 component Allergan Inc. reported its results for the fourth quarter. Allergan is a global specialty health care company.

Comment?

Related Topix: Biotech, Allergan

Wed Feb 01, 2012

Wall St. Cheat Sheet

Allergan and Cigna Keep Shareholders Anxious Ahead of Earnings

Allergan, Inc. will unveil its latest earnings on Thursday, February 2, 2012. The average estimate of analysts is for profit of $1 per share, a rise of 13.6% from the company's actual earnings for the same quarter a year ago.

Comment?

Related Topix: Startups, Micrus, Biotech, Cigna, Insurance, Johnson and Johnson, Medicine, Healthcare Industry, Inspire Pharmaceuticals, ISTA Pharmaceuticals

Tue Jan 31, 2012

Stock Market Review

Earnings Preview: Allergan - Analyst Blog

Allergan, Inc. is scheduled to announce its fourth quarter and full year 2011 results on February 2, 2012, before the opening bell.

Comment?

Related Topix: Biotech

Mon Jan 30, 2012

Forbes.com

Forbes Earnings Preview: Allergan

Optimism surrounds Allergan , as it gets ready to report its fourth quarter results on Thursday, February 2, 2012.

Comment?

Related Topix: Biotech, Financial Markets

Los Angeles Jobs

Also on Topix